Showing results (371-380 of 447) with videos related to
Sort By:
Pageof 45
Cardio-Oncology (London, England)|August 13, 2020
Atlas-based measures of left ventricular shape may improve characterization of adverse remodeling in anthracycline-exposed childhood cancer survivors: a cross-sectional imaging studyHari K Narayan, Ronghui Xu, Nickolas Forsch, et al.Cardio-Oncology (London, England)|July 21, 2020
Outcomes after transcatheter aortic valve replacement in cancer survivors with prior chest radiation therapy: a systematic review and meta-analysisMeer Rabeel Zafar, Syed Farrukh Mustafa, Timothy W Miller, et al.Cardio-Oncology (London, England)|July 28, 2020
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunctionMaria Isabel Camara Planek, Ahmad Manshad, Kyaw Hein, et al.Cardio-Oncology (London, England)|May 19, 2023
The association of QTc prolongation with cardiovascular events in cancer patients taking tyrosine kinase inhibitors (TKIs)Ismail Ghafary, Chang-Kyung Kim, Eric Roth, et al.Cardio-Oncology (London, England)|February 23, 2023
Endothelial function measured by peripheral arterial tonometry in patients with chronic myeloid leukemia on tyrosine kinase inhibitor therapy: a pilot studyTomohiro Kaneko, Sakiko Miyazaki, Azusa Kurita, et al.Cardio-Oncology (London, England)|August 9, 2022
Early access to a cardio-oncology clinic in an Australian context: a qualitative exploration of patient experiencesJennifer White, Julie Byles, Trent Williams, et al.Cardio-Oncology (London, England)|March 21, 2023
Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppressionKhan O Mohammad, Hanna Fanous, Sneha Vakamudi, et al.Cardio-Oncology (London, England)|March 2, 2023
The association of preoperative high-sensitivity cardiac troponin i and long-term outcomes in colorectal cancer patients received tumor resection surgeryYitao Zhang, Zicheng Huang, Sutian Hu, et al.Cardio-Oncology (London, England)|March 9, 2023
Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapyAnthony F Yu, Chau T Dang, Justine Jorgensen, et al.Cardio-Oncology (London, England)|November 19, 2022
Exercise-induced Brugada pattern and ventricular tachycardia during Capecitabine treatmentGeorge B Strobel, Shiva P Ponamgi, Attila Roka, et al.Pageof 45